← Back to directory

Matti Aapro

Researcher Next ID · RN-034195

Researcher · Biochemistry, Genetics and Molecular Biology

Clinique de Genolier

Genolier, Switzerland

Accepting doctoral researchersFunding unknown
Works count
855
Citation count
43,952
H-index
104
i10-index
368

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Nausea and vomiting management
Cancer Treatment and Pharmacology
Breast Cancer Treatment Studies
Neutropenia and Cancer Infections
Erythropoietin and Anemia Treatment

Publications

  • 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

    Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.09.010

  • Bone health in cancer: ESMO Clinical Practice Guidelines

    Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.07.019

  • Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients

    European Journal of Cancer · 2019 · https://doi.org/10.1016/j.ejca.2019.04.031

  • Integration of oncology and palliative care: a Lancet Oncology Commission

    The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30415-7

  • 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

    Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy192

  • European Society for Medical Oncology (ESMO) position paper on supportive and palliative care

    Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx757

  • Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

    Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx758

  • Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG

    Journal of bone oncology · 2017 · https://doi.org/10.1016/j.jbo.2017.03.001

  • 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    Annals of Oncology · 2016 · 10.1093/annonc/mdw544

  • 3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)

    The Breast · 2016 · https://doi.org/10.1016/j.breast.2016.10.001

  • Management of febrile neutropaenia: ESMO Clinical Practice Guidelines

    Annals of Oncology · 2016 · 10.1093/annonc/mdw325

  • 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

    Annals of Oncology · 2016 · 10.1093/annonc/mdw270

  • Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting

    New England Journal of Medicine · 2016 · 10.1056/nejmra1515442

  • Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel

    Annals of Oncology · 2015 · https://doi.org/10.1093/annonc/mdv617

  • ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

    Annals of Oncology · 2014 · https://doi.org/10.1093/annonc/mdu385

  • Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology

    The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70018-x

  • ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

    The Breast · 2014 · https://doi.org/10.1016/j.breast.2014.08.009

  • Bone health in cancer patients: ESMO Clinical Practice Guidelines

    Annals of Oncology · 2014 · 10.1093/annonc/mdu103

  • Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013

    Annals of Oncology · 2014 · 10.1093/annonc/mdu253

  • 1st International consensus guidelines for advanced breast cancer (ABC 1)

    The Breast · 2012 · https://doi.org/10.1016/j.breast.2012.03.003

  • Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)

    The Lancet Oncology · 2012 · 10.1016/s1470-2045(11)70383-7

  • The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)

    Annals of Oncology · 2012 · https://doi.org/10.1093/annonc/mds021

  • Delivering affordable cancer care in high-income countries

    The Lancet Oncology · 2011 · 10.1016/s1470-2045(11)70141-3

  • 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

    European Journal of Cancer · 2010 · https://doi.org/10.1016/j.ejca.2010.10.013

  • Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

    Annals of Oncology · 2010 · 10.1093/annonc/mdq194

  • Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

    Annals of Oncology · 2007 · 10.1093/annonc/mdm442

  • EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

    European Journal of Cancer · 2006 · https://doi.org/10.1016/j.ejca.2006.10.014

  • EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

    European Journal of Cancer · 2006 · https://doi.org/10.1016/j.ejca.2006.05.002

  • Use of comprehensive geriatric assessment in older cancer patients:

    Critical Reviews in Oncology/Hematology · 2005 · 10.1016/j.critrevonc.2005.06.003

  • Cancer-Related Anemia: Pathogenesis, Prevalence and Treatment

    Oncology · 2005 · https://doi.org/10.1159/000083128

  • EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer

    European Journal of Cancer · 2004 · https://doi.org/10.1016/j.ejca.2004.07.015

  • Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

    Annals of Oncology · 2003 · 10.1093/annonc/mdg417

  • Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

    Annals of Oncology · 2003 · https://doi.org/10.1093/annonc/mdg112

  • Comprehensive Geriatric Assessment Adds Information to Eastern Cooperative Oncology Group Performance Status in Elderly Cancer Patients: An Italian Group for Geriatric Oncology Study

    Journal of Clinical Oncology · 2002 · 10.1200/jco.2002.20.2.494

  • Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

    Journal of Clinical Oncology · 1999 · 10.1200/jco.1999.17.5.1413

  • Proposal for classifying the acute emetogenicity of cancer chemotherapy.

    Journal of Clinical Oncology · 1997 · 10.1200/jco.1997.15.1.103

  • Cancer in the elderly: why so badly treated?

    The Lancet · 1990 · 10.1016/0140-6736(90)91075-l

Current projects

    No projects listed.